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ABSTRACT
Achromobacter xylosoxidans is an environmental bacte-
rium with multi-drug resistance. We isolated Achromo-
bacter xylosoxidans and investigated its susceptibility 
to 13 drugs. Seventy-eight water samples were collected 
from rivers and ponds, and 11 samples were swabbed 
from residential sinks and baths. Nine strains of Achro-
mobacter xylosoxidans were isolated from the 89 sam-
ples. Five strains, including 2 that were sampled from 
residential homes, showed high resistance to multiple 
aminoglycosides. This indicated that Achromobacter xy-
losoxidans is widely distributed in various outdoor and 
indoor environments. Moreover, since these highly resis-
tant bacteria were present in indoor environments, cau-
tion should be taken for elderly people living at home. 
Furthermore, a careful assessment should be made for 
diagnosing and treating compromised hosts. 
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Achromobacter xylosoxidans (A. xylosoxidans) is a cata-
lase-positive, oxidase-positive, and glucose-non-ferment-
ing Gram-negative rod. Non-fermenting Gram-negative 
rods have similar properties and are difficult to differ-
entiate.1 Furthermore, since A. xylosoxidans is an envi-
ronmental pathogen, it is usually overlooked in routine 
clinical examinations. A. xylosoxidans is an opportunis-
tic bacterium with multi-drug resistance and infections 
are known to cause clinical difficulties since it becomes 
chronic and refractory.2 
 We previously reported a rare case whereby a 
strain classified as multidrug-resistant Pseudomonas 
aeruginosa (P. aeruginosa) was further identified as 
drug-susceptible P. aeruginosa and multidrug-resistant 
A. xylosoxidans.3 Based on this experience, we became 
aware of the importance of surveying the environmental 
distribution and drug-susceptibility of A. xylosoxidans 
existing in nature. We devised an isolation procedure 
suited for the properties of A. xylosoxidans, isolated it 
from various environmental samples, and investigated 
the environmental distribution and drug susceptibility 
of the isolates. The results suggest that more attention to 
this species is necessary.
MATERIALS AND METHODS
Culture media
Heart Infusion broth including Vancomycin and Aztreo-
nam (HIVA) broth was prepared by adding 32 μg/mL of 
vancomycin and aztreonam to heart infusion broth and 
was used as an enrichment medium. Xylose-Macconkey 
agar including Vancomycin and Aztreonam (X-MacVA) 
agar plate was prepared by adding 1% xylose (X) and 
20 μg/mL of vancomycin and aztreonam to MacConkey 
agar and was used as an isolation medium.2 
Method for isolation from the environment
Samples were collected from rivers, ponds, irrigation 
ditches, and residential homes within an area of 20 km 
of the Yumigahama Peninsula in the west area of Tottori 
Prefecture, Japan. The samples were either collected in 
volumes of 15 mL from outdoor water sources or ob-
tained from drains of residential sinks and baths using 
sterilized swabs, which was subsequently suspended 
with 15 mL of distilled water. These samples were cen-
trifuged at 4,000 × g for 15 minutes, and the sediment 
was cultured in HIVA broth 72 h at 35 °C. Cultured 
bacterial fluid was cultured on X-MacVA agar 72 h at 
35 °C. The colonies that formed on the agar were typed, 
and the number of colony types was regarded as the 
number of isolated colonies. A typical colony in each 
colony type was subjected to differentiation tests. Of 
the bacteria determined to be Gram-negative rods, only 
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Table 1. The state of isolation of Achromobacter xylosoxidans from environmental materials and the MICs of   
13 antibacterial drugs against environmentally isolated Achromobacter xylosoxidans
Samples
n
Number of colonies Antibiotics MIC (µg/mL)                     AGs
Isolated
n
Differen-
tiated n
Identifi ed
n
Identifi ed
name PIPC CFPM AZT IMP CPFX AMK GM SPCT SM KM TOB NET NEO
Water 
78 57 45 6
W1 0.5 8 128 1 1 8 4 128 ≥ 128 8 4 4 16
W2 0.25 8 128 1 2 128 32 128 16 128 8 4 128
W3 0.5 4 128 1 1 4 2 ≥ 128 64 8 2 2 8
W4 1 32 64 4 2 ≥ 128 ≥ 128 ≥ 128 ≥ 128 128 64 128 ≥ 128
W5 0.25 8 128 1 2 4 2 128 32 8 2 2 8
W6 16 32 128 1 4 64 64 ≥ 128 ≥ 128 128 16 32 128
Swabs
11 8 8 3
S1 0.5 32 128 2 8 ≥ 128 128 ≥ 128 ≥ 128 ≥ 128 64 128 ≥ 128
S2 0.5 32 64 2 2 ≥ 128 ≥ 128 ≥ 128 128 64 64 128 ≥ 128
S3 0.25 8 128 1 1 4 2 128 64 8 2 4 8
Achromobacter xylosoxidans 600S 0.5 128 128 1 16 ≥ 128 ≥ 128 ≥ 128 ≥ 128 ≥ 128 ≥ 128 ≥ 128 ≥ 128
Samples: water; rivers, ponds, irrigation ditches, swabs; the drains of residential sinks and baths. 
Drugs:AG; aminoglycoside; AMK, amikacin; AZT, aztreonam; CFPM, cefepime; CPFX, ciprofl oxacin; GM, gentamicin; IMP, imipen-
em; KM, kanamycin; NEO, neomycin; NET, netilmicin; PIPC, piperacillin; SPCT, spectinomycin; SM, streptomycin; TOB, tobramycin. 
MIC, minimal inhibition concentration. 
Fig. 1. Map of the sampling 
points and A. xylosoxidans 
isolation. Map of the Yumi-
gahama Peninsula extending 
from Yonago City to Sakaim-
inato City, Tottori Prefecture, 
Japan. The sampling points of 
A. xylosoxidans-positive and 
-negative materials are indicat-
ed as  and , respectively. 
Sample numbers are shown in 
the symbols. A. xylosoxidans, 
Achromobacter xylosoxidans. 
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those that were positive for catalase and oxidase tests 
were further tested for their non-fermentability, growth 
ability in stab culture, citrate utilization ability, and 
nitrate-reducing ability. These differential test-positive 
bacteria were identified using ID test NF-18 (Nissui 
Pharmaceutical, Tokyo, Japan), a simple identification 
kit for glucose-non-fermenting Gram-negative rods. A 
fi nal identifi cation was made according to a 16S rDNA 
base sequence.4 
Bacterial strains
Nine environmentally isolated A. xylosoxidans and A. 
xylosoxidans 600S strains3 were used. 
Drug susceptibility tests
The minimal inhibition concentration (MIC) was de-
termined by the agar plate dilution method using the 
Clinical and Laboratory Standard Institute procedure. 
The following drugs were tested: piperacillin (PIPC), 
cefepime (CFPM), aztreonam (AZT), imipenem (IPM), 
ciprofloxacin (CPFX), amikacin (AMK), gentamicin 
(GM), streptomycin (SM), kanamycin (KM), netilmicin 
(NET), spectinomycin (SPCT), neomycin (NEO) and 
tobramycin (TOB). 
RESULTS
Table 1 shows the isolation state of A. xylosoxidans from 
various samples and the MICs of 13 antibacterial drugs 
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for the isolated A. xylosoxidans. Figure 1 shows the map 
of the sampling points and A. xylosoxidans isolation. 
State of isolation
Of the 89 samples, 9 strains of A. xylosoxidans were 
identified. The identification rate was 10.1% (6 strains 
(7.7%) in outdoor water samples and 3 strains (27.3%) 
in swab samples from residential homes) (Table 1). The 
species was identified in a wide sampling area (Fig. 1).
Evaluation of the isolation and identification meth-
ods
The number of isolated colonies that formed on X-Mac-
VA agar was low, at around 70% per sample. The differ-
entiation tests showed that 81.5% of the isolated colonies 
were positive for oxidase and catalase. Based on the 
bacterial identification tests, 10.1% of the colonies were 
identified as A. xylosoxidans. Furthermore, according to 
the isolation and identification protocol, of the red col-
onies that formed on X-MacVA agar, the large colonies 
were identified as Pseudomonas fluorescens and the pin-
point colonies as A. xylosoxidans. Finally, A. xylosoxi-
dans was confirmed using the 16 rDNA base sequence.
Drug susceptibility tests
The strains were susceptible to β-lactams (PIPC, IMP, 
CFPM) except for monobactam (AZT), and new quino-
lone (CPFX). Of the 8 aminoglycosides (AGs; AMK, 
GM, SPCT, SM, KM, TOB, NET, NEO) that were 
tested, the MIC of SPCT was 128~ ≥ 128 μg/mL for 
all strains. However, drugs other than SPCT and SM 
had low MICs for 4 strains (W2, W3, W5, S3) and high 
MICs for 5 strains (W1, W4, W6, S1, S2), which closely 
resembled the resistance pattern of the A. xylosoxidans 
600S strain. Of the 5 multidrug-resistant strains (W2, 
W4, W6, S1, S2) in all, 2 were isolated from residential 
homes (S1, S2) (Table 1).
DISCUSSION
Since A. xylosoxidans is an environmental bacterium, it 
is rarely detected in routine clinical examinations, and, 
if it is detected, its differentiation and identification is 
difficult as it is often mistaken for P. aeruginosa. A. xy-
losoxidans has multidrug resistance and erroneous iden-
tification of the bacteria will lead to inappropriate se-
lection of drugs. Therefore, information concerning the 
distribution of this species and the drug susceptibility of 
bacteria distributed in the environment is important.
 The enrichment and isolation media used in this 
study, which included AZT resistance and xylose de-
gradability, showed high selectivity. Red colonies that 
formed on X-MacVA agar were likely glucose-non-fer-
menting Gram-negative Pseudomonas and A. xylosoxi-
dans. Pin-point colonies, in particular, were considered 
to be an important criterion for detecting A. xylosox-
idans.2 Although the differential tests are effective for 
confirming major properties of bacteria, they are not able 
to precisely determine the species. Therefore, a definitive 
diagnosis based on the 16S rDNA base sequence is im-
portant. Since Pseudomonas and A. xylosoxidans have 
similar properties, they are often misidentified or over-
looked due to differences in their growth ability.3 Proper 
knowledge regarding the properties of A. xylosoxidans 
is necessary to avoid misdiagnoses in routine examina-
tions.
 Amoureux et al.2 isolated A. xylosoxidans in a wide 
area and reported identification rates of 28% and 12% 
from samples collected from the outdoor and indoor en-
vironments, respectively. In our study, the identification 
rate for samples collected from indoor residences was 
high at approximately 30% for bath drains. In contrast, 
the identification rate was relatively low for outdoor wa-
ter sources, which may have been due to the small sam-
ple volume of 15 mL. In addition, A. xylosoxidans has a 
biofilm-forming ability.5 Biofilm can form in the drains 
of sinks and baths, which may have led to the high bac-
terial concentrations in the swab samples. Considering 
these points, we deem our bacterial isolation procedure 
appropriate. Furthermore, the wide distribution of this 
species in indoor environments was demonstrated.
 The 9 strains of A. xylosoxidans isolated from the 
various environments resembled the common multi-
drug resistance pattern,6 and some drugs showed for 
high MICs, AGs in particular. The MICs of the 8 AGs 
for the A. xylosoxidans 600S strain 3 were ≥ 128 μg/
mL, and 5 (W2, W4, W6, S1, S2) strains were isolated 
from both the outdoor and indoor samples. Since A. 
xylosoxidans can be mistaken for P. aeruginosa, care is 
necessary when selecting drugs for Gram-negative rod 
infections. In addition, this species is drug-resistant and 
is distributed in wet areas. The latter feature may cause 
problems since the bacteria may accumulate in the sinks 
of residential kitchens and baths. Currently, residences 
of elderly people in need of medical and nursing care 
are increasingly transitioning from medical facilities to 
residential homes, especially care homes for the elderly. 
Sufficient attention is necessary for vulnerable elderly 
people and compromised hosts who live at home. 
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